Transglutaminase 2 (TG2) is a multifunctional protein that modulates cell survival and death pathways. It is upregulated in numerous ischemic models, and protects primary neurons from oxygen and glucose deprivation. TG2 binds to the hypoxia inducible factor (HIF) 1β and decreases the upregulation of hypoxicinduced proapoptotic genes. To investigate the role of TG2 in ischemic stroke in vivo, we used the murine, permanent middle cerebral artery (MCA) ligation model. TG2 mRNA levels are increased after MCA ligations, and transgenic mice that express human TG2 in neurons had significantly smaller infarct volumes than wild type littermates. Further, TG2 translocates into the nucleus within 2 h post ligation. Nuclear-localized TG2 is also apparent in human stroke cases. TG2 suppressed the upregulation of the HIF-induced, proapoptotic gene, Noxa. The findings of this study indicate that TG2 plays a role in attenuating ischemic-induced cell death possibly by modulating hypoxic-induced transcriptional processes.
Introduction
Stroke is a major cause of adult acquired disability. Inadequate delivery of oxygen and glucose to cerebral tissue initiates numerous processes including excitotoxic and apoptotic cell death, as well as adaptive responses in the penumbra (tissue surrounding the core of the stroke; (Aarts and Tymianski, 2004; Sharp et al., 2000) ). Molecular mechanisms in response to stroke that dictate cell survival or eventual death in the penumbra are incompletely understood. It is clear, however, that transcriptional processes play key roles.
A decrease in oxygen delivery activates hypoxic signaling, with hypoxia inducible factors (HIFs; (Wang et al., 1995) ) being responsible for the majority of changes in gene expression. The extent and cell type specificity of HIF activation results in alternative outcomes regarding cell fate (Baranova et al., 2007; Chen et al., 2008; Vangeison et al., 2008) with the differential upregulation of both pro-survival and pro-death genes (Aminova et al., 2005; Dayan et al., 2006; Hu et al., 2007) . One protein upregulated in ischemia that has previously been shown to regulate cell death and survival pathways is Transglutaminase 2 (TG2) (Ientile et al., 2004; Tolentino et al., 2004) . Although the mechanism of TG2 upregulation in hypoxia remains unclear, TG2 has recently been shown to be directly regulated by HIF (Jang et al., 2009 ). TG2 binds the constitutively expressed subunit of HIF, HIF1β, attenuates HIF signaling, and protects against oxygen and glucose deprivation (OGD)-induced cell death in neurons and human neuroblastoma cells (Filiano et al., 2008) . The impact of TG2 in modulating stroke damage has not yet been investigated.
TG2 is a multifunctional protein. In addition to its transamidating activity, TG2 has GTPase, kinase, and protein disulphide isomerase activities, as well as scaffolding/linker properties (Fesus and Piacentini, 2002; Hasegawa et al., 2003; Milakovic et al., 2004; Mishra and Murphy, 2004) . The ability of TG2 to interact with numerous proteins may be due to its ability to take on different structural conformations (Liu et al., 2002; Pinkas et al., 2007) and/or its subcellular localization (Gundemir and Johnson, 2009; Milakovic et al., 2004) . A primary role of TG2 is modulating transcription by interacting with specific regulatory proteins; especially those affecting cell survival after insults (Ahn et al., 2008; Filiano et al., 2008; Lee et al., 2004) .
TG2 belongs to a family of 9 transglutaminases, of which 8 have catalytic activity (Lorand and Graham, 2003) . The transamidating reaction catalyzed by transglutaminases can yield protein crosslinks or incorporation of polyamines into proteins. Transglutaminases can also catalyze the deamidation of proteins (Lorand and Graham, 2003) . While earlier studies focused on TG2's transamidating activity, it is now clear that this activity is tightly controlled and predominantly inactive (Begg et al., 2006; Siegel et al., 2008) and is not required to protect against OGD-induced cell death (Filiano et al., 2008) or death induced by other stressors (Milakovic et al., 2004) . 
